日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression

具有人类 scFv 的嵌合抗原受体优先诱导针对 B7H6 高表达肿瘤的 T 细胞抗肿瘤活性

Albert T Gacerez, Casey K Hua, Margaret E Ackerman, Charles L Sentman

T-bet promotes potent antitumor activity of CD4+ CAR T cells

T-bet 增强 CD4+ CAR T 细胞的强效抗肿瘤活性

Albert T Gacerez, Charles L Sentman

Computationally-driven identification of antibody epitopes

计算驱动的抗体表位鉴定

Hua, Casey K; Gacerez, Albert T; Sentman, Charles L; Ackerman, Margaret E; Choi, Yoonjoo; Bailey-Kellogg, Chris

Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6

基于人类 scFv 靶向 B7H6 的独特细胞毒性嵌合抗原受体的开发

Casey K Hua, Albert T Gacerez, Charles L Sentman, Margaret E Ackerman

How Chimeric Antigen Receptor Design Affects Adoptive T Cell Therapy

嵌合抗原受体设计如何影响过继性T细胞疗法

Gacerez, Albert T; Arellano, Benjamine; Sentman, Charles L

B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity

B7H6 特异性双特异性 T 细胞接合剂可消除肿瘤并产生宿主抗肿瘤免疫力

Ming-Ru Wu, Tong Zhang, Albert T Gacerez, Tiffany A Coupet, Leslie R DeMars, Charles L Sentman